Inhaled corticosteroids moderate lung function decline in adults with asthma
- PMID: 16443701
- PMCID: PMC2104573
- DOI: 10.1136/thx.2005.042010
Inhaled corticosteroids moderate lung function decline in adults with asthma
Abstract
Further evidence of the benefit of long term inhaled corticosteroids in asthma
Conflict of interest statement
Competing interests: Pierre Ernst has received speaker fees from and/or is on advisory boards of Altana, Astra Zeneca, GlaxoSmithKline, Merck, and Novartis.
Comment on
-
Inhaled corticosteroids and decline of lung function in community residents with asthma.Thorax. 2006 Feb;61(2):100-4. doi: 10.1136/thx.2004.037978. Thorax. 2006. PMID: 16443705 Free PMC article.
References
-
- Barnes P J. Inhaled glucocorticoids for asthma. N Engl J Med 1995332868–875. - PubMed
-
- Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001107937–944. - PubMed
-
- Pauwels R A, Pedersen S, Busse W W.et al Early intervention with budesonide in mild persistent asthma: a randomised, double‐blind trial. Lancet 20033611071–1076. - PubMed
-
- Boushey H A, Sorkness C A, King T S.et al Daily versus as‐needed corticosteroids for mild persistent asthma. N Engl J Med 20053521519–1528. - PubMed